Press release
Global Clot Management Devices is expected to attain a market size of $1.7billion by 2022
KBV Research
The Percutaneous Thrombectomy Devices market dominated the Global Clot Management Market by Product in 2015, and would continue to be a dominant market till 2022; thereby, achieving a market value of $605.7 million by 2022, growing at a CAGR of 3.6% during the forecast period. The Hospitals market dominated the Global Clot Management Market by End User in 2015, and would continue to be a dominant market till 2022; growing at a CAGR of 4.3% during the forecast period. The Diagnostic Centers market is expected to witness a CAGR of 7.5% during (2016-2022).
The North America market dominated the Global Clot Management Market by Region in 2015, and would continue to be a dominant market till 2022; growing at a CAGR of 2.7% during the forecast period. The Asia-Pacific market is expected to witness a CAGR of 7.8% during (2016-2022). The report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key influencing factors of the global Clot Management Devices have been discussed in the report along with the elaborated company profiles of Teleflex Inc., Edwards Lifesciences Corporation, Medtronic Plc, Boston Scientific Corporation, Lemaitre Vascular, Inc., Straub Medical AG, Cook Medical Inc. and Johnson & Johnson.
Full Report: http://kbvresearch.com/global-clot-management-devices-market/
Research Scope
Global Clot Management Devices Market by Product Type
• Percutaneous Thrombectomy Devices
• Embolectomy Balloon Catheters
• Catheter-Directed Thrombolysis (CDT) devices
• Neurovascular Embolectomy Devices
• Inferior vena cava filters Professional
Global Clot Management Devices Market by End User
• Hospitals
• Diagnostic Centers
Global Clot Management Devices Market by Geography
• North America Clot Management Devices Market
o US. Clot Management Devices Market
o Canada Clot Management Devices Market
o Mexico Clot Management Devices Market
o Rest of North America Clot Management Devices Market
• Europe Clot Management Devices Market
o Germany Clot Management Devices Market
o U.K. Clot Management Devices Market
o France Clot Management Devices Market
o Russia Clot Management Devices Market
o Spain Clot Management Devices Market
o Italy Clot Management Devices Market
o Rest of Europe Clot Management Devices Market
• Asia-Pacific Clot Management Devices Market
o China Clot Management Devices Market
o Japan Clot Management Devices Market
o India Clot Management Devices Market
o South Korea Clot Management Devices Market
o Singapore Clot Management Devices Market
o Malaysia Clot Management Devices Market
o Rest of Asia-Pacific Clot Management Devices Market
• LAMEA Clot Management Devices Market
o Brazil Clot Management Devices Market
o Argentina Clot Management Devices Market
o UAE Clot Management Devices Market
o Saudi Arabia Clot Management Devices Market
o South Africa Clot Management Devices Market
o Nigeria Clot Management Devices Market
o Rest of LAMEA Clot Management Devices Market
Companies Profiled
• Teleflex Inc.
• Edwards Lifesciences Corporation
• Medtronic Plc
• Boston Scientific Corporation
• Lemaitre Vascular, Inc.
• Straub Medical AG
• Cook Medical Inc.
• Johnson & Johnson
Unique Offerings from KBV Research
• Exhaustive coverage of Global Clot Management Devices Market
• Highest number of market tables and figures
• Subscription based model available
• Free of cost quarterly updates
• Guaranteed best price
• Assured post sales research support with 10% customization free
Related Reports:
North America Clot Management Devices Market
Europe Clot Management Devices Market
Asia Pacific Clot Management Devices Market
LAMEA Clot Management Devices Market
244 Fifth Avenue, Suite 1407
New York, N.Y. 10001
United States (U.S)
Tel: +1 (646) 661-6066
Email : info@kbvresearch.com
244 Fifth Avenue, Suite 1407 New York, N.Y., https://kbvresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Clot Management Devices is expected to attain a market size of $1.7billion by 2022 here
News-ID: 1457047 • Views: …
More Releases from KBV Research
Push to Talk Market to reach a market size of $43.8 billion by 2025- KBV Researc …
According to a new report Global Push to Talk Market, published by KBV Research, The Global Push to Talk Market size is expected to reach $43.8 billion by 2025, rising at a market growth of 10.1% CAGR during the forecast period. Key factors expected to influence the push-to-talk market growth include increased adoption of push-to-talk over cellular (PoC) in commercial verticals, mass adoption of the mobile-first strategy by pushing vendors…
Bakery Processing Equipment Market to reach a market size of $17.9 billion by 20 …
According to a new report Global Bakery Processing Equipment Market, published by KBV Research, The Global Bakery Processing Equipment Market size is expected to reach $17.9 billion by 2025, rising at a market growth of 6.17% CAGR during the forecast period.
The ovens and proofers equipment sub-segment held the dominant market share in 2018. In the production of bakery products, ovens and proofers are used to a large extent. Molders and…
Caffeinated Beverage Market to reach a market size of $310.5 billion by 2025- KB …
According to a new report Global Caffeinated Beverage Market, published by KBV Research, The Global Caffeinated Beverage Market size is expected to reach $310.5 billion by 2025, rising at a market growth of 6.8% CAGR during the forecast period.
The North America market dominated the Global Caffeinated Beverage Market by Region in 2018, thereby, achieving a market value of $123,505.8 million by 2025, growing at a CAGR of 6.1 % during…
Acute Hospital Care Market to reach a market size of $3.5 billion by 2025- KBV R …
According to a new report Global Acute Hospital Care Market, published by KBV Research, The Global Acute Hospital Care Market size is expected to reach $3,573.3 billion by 2025, rising at a market growth of 7.04% CAGR during the forecast period. The Emergency Care market dominated the Global Acute Hospital Care Market by Medical Condition in 2018, and would continue to be a dominant market till 2025; thereby, achieving a…
More Releases for Clot
Top Factor Driving Clot Management Devices Market Growth in 2025: Rising Hospita …
How Big Is the Clot Management Devices Market Expected to Be, and What Will Its Growth Rate Be?
The market for clot management devices has seen significant growth in recent years. The market is expected to expand from a value of $1.72 billion in 2024 to approximately $1.83 billion in 2025, representing a compound annual growth rate (CAGR) of 6.4%. This growth during the historical period can be linked to factors…
Clot Management Devices Market Report 2024 - Clot Management Devices Market Shar …
"The Business Research Company recently released a comprehensive report on the Global Clot Management Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Clot Management Devices Market Is Driven By Clot Management Devices In Various I …
The Clot Management Devices Market is experiencing significant growth and innovation, primarily due to the increasing incidence of thromboembolic diseases and the rising awareness of the importance of efficient clot removal techniques. Thromboembolic conditions, such as deep vein thrombosis (DVT) and pulmonary embolism, pose substantial risks to patient health and can result in life-threatening situations. Clot management devices, which include catheters, aspiration systems, and mechanical thrombectomy devices, play a crucial…
Blood Clot Retrieval Devices Market - From Clot to Flow: Blood Clot Retrieval De …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Blood Clot Retrieval Devices Market.
Blood Clot Retrieval Devices Market: https://www.growthplusreports.com/report/blood-clot-retrieval-devices-market/9174
The Blood Clot Retrieval Devices Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends…
Rivaroxaban Market Insights – Stop the Clot
Rivaroxaban is a Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) that is marketed as Xarelto. Anticoagulant medicines are potent therapeutic agents used in the prevention or treatment of serious illnesses and potentially life-threatening conditions associated with blood coagulation. Rivaroxaban was discovered by Bayer and is being jointly developed with Janssen Research & Development, LLC. Xarelto is approved for indications such as stroke prevention in non-valvular atrial fibrillation, pulmonary embolism, deep vein…
Clot Management Devices Market: Global Markets & Advanced Technologies
Global Clot Management Devices Market: Overview
According to an article published in the Journal of Thrombosis and Haemostasis, the awareness about venous thromboembolism (VTE) remains alarmingly low. What makes this scenario more concerning is that nearly 10 million VTE cases are estimated to occur every year across the world making this condition among the leading causes of disability worldwide. The International Society on Thrombosis and Haemostasis, Inc. states that while…
